Skip to main content
SpringerLink
Log in

Liver-Directed Therapy for Metastatic Melanoma to the Liver

  • Chapter
  • First Online:
Liver Metastases

  • 912 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004; 54(1): 8–29.

    Article  PubMed  Google Scholar 

  2. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 2003; 110(5): 956–61.

    Article  PubMed  Google Scholar 

  3. Reintgen DS, Cox C, Slingluff CL Jr, Seigler HF. Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg. 1992; 28(1): 45–9.

    Article  PubMed  CAS  Google Scholar 

  4. Soong SJ, Harrison RA, McCarthy WH, et al. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol. 1998; 67(4): 228–33.

    Article  PubMed  CAS  Google Scholar 

  5. Becker JC, Terheyden P, Kampgen E, et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer. 2002; 87(8): 840–5.

    Article  PubMed  CAS  Google Scholar 

  6. Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol. 2004; 86(4): 172–8.

    Article  PubMed  Google Scholar 

  7. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, et al. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncol. 1999; 38(5): 549–57.

    Article  PubMed  CAS  Google Scholar 

  8. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 2001; 136(8): 950–5.

    Article  PubMed  CAS  Google Scholar 

  9. Branum GD, Epstein RE, Leight GS, Seigler HF. The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery. 1991;109(2): 127–31.

    PubMed  CAS  Google Scholar 

  10. Mosimann F, Fontolliet C, Genton A, et al. Resection of metastases to the alimentary tract from malignant melanoma. Int Surg. 1982; 67(3): 257–60.

    PubMed  CAS  Google Scholar 

  11. de Wilt JH, McCarthy WH, Thompson JF. Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg. 2003; 197(1): 38–43.

    Article  PubMed  Google Scholar 

  12. Lejeune FJ, Lienard D, Sales F, Badr-el-Din H. Surgical management of distant melanoma metastases. Semin Surg Oncol. 1992; 8(6): 381–91.

    Article  PubMed  CAS  Google Scholar 

  13. Wong JH, Euhus DM, Morton DL. Surgical resection for metastatic melanoma to the lung. Arch Surg. 1988; 123(9): 1091–5.

    Article  PubMed  CAS  Google Scholar 

  14. Augsberger JJ, Damato BE, Bornfeld N. Uveal melanoma. In: Yanoff M, Duker JS, Augsberger JJ, eds. Ophthalmology. St. Louis: Mosby; 2004.

    Google Scholar 

  15. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg. 1978; 135(6): 807–10.

    CAS  Google Scholar 

  16. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer. 1983; 52(2): 334–6.

    Article  PubMed  CAS  Google Scholar 

  17. Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand. 1995; 73(4): 340–4.

    CAS  Google Scholar 

  18. Conway RM, Chua WC, Qureshi C, Billson FA. Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment. Br J Ophthalmol. 2001; 85(7): 848–54.

    Article  PubMed  CAS  Google Scholar 

  19. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001; 11(3): 255–63.

    Article  PubMed  CAS  Google Scholar 

  20. Bedikian AY, Kantarjian H, Young SE, Bodey GP. Prognosis in metastatic choroidal melanoma. South Med J. 1981; 74(5): 574–7.

    Article  PubMed  CAS  Google Scholar 

  21. Albert DM, Niffenegger AS, Willson JK. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol. 1992; 36(6): 429–38.

    Article  PubMed  CAS  Google Scholar 

  22. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991; 98(3): 383–9; discussion 390.

    PubMed  CAS  Google Scholar 

  23. Einhorn LH, Burgess MA, Gottlieb JA. Metastatic patterns of choroidal melanoma. Cancer. 1974; 34(4): 1001–4.

    Article  PubMed  CAS  Google Scholar 

  24. Shields JA, Augsburger JJ, Donoso LA, et al. Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol. 1985; 100(5): 666–8.

    PubMed  CAS  Google Scholar 

  25. Sato T, Babazono A, Shields JA, et al. Time to systemic metastases in patients with posterior uveal melanoma. Cancer Invest. 1997; 15(2): 98–105.

    Article  PubMed  CAS  Google Scholar 

  26. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005; 123(12): 1639–43.

    Google Scholar 

  27. Ries LG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review 1975–2003. National Cancer Institute; http://seer.cancer.gov/csr/1975_2003/ posted 2006.

  28. Leong SP, Cady B, Jablons DM, et al. Clinical patterns of metastasis. Cancer Metastasis Rev. 2006; 25(2): 221–32.

    Article  PubMed  Google Scholar 

  29. Albert DM, Ryan LM, Borden EC. Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis. Arch Ophthalmol. 1996; 114(1): 107–8.

    Article  PubMed  CAS  Google Scholar 

  30. Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006; 13(5): 712–20.

    Article  PubMed  Google Scholar 

  31. Del Prete SA, Maurer LH, O’Donnell J, et al. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep. 1984; 68(11): 1403–5.

    PubMed  CAS  Google Scholar 

  32. Chapman PB, Einhorn LH, Meyers ML, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999; 17(9): 2745–51.

    PubMed  CAS  Google Scholar 

  33. O’Day SJ, Kim CJ, Reintgen DS. Metastatic melanoma: chemotherapy to biochemotherapy. Cancer Control. 2002; 9(1): 31–8.

    PubMed  Google Scholar 

  34. Nathan FE, Sato T, Hart E, et al. Response to combination chemotherapy of liver metastases from choroidal melanoma compared with cutaneous melanoma. Amer Soc Clin Oncol. 1994; 13: 396.

    Google Scholar 

  35. Pyrhonen S. The treatment of metastatic uveal melanoma. Eur J Cancer. 1998; 34(Suppl 3): S27–30.

    Article  PubMed  Google Scholar 

  36. Nathan FE, Berd D, Sato T, et al. BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res. 1997; 16(2): 201–8.

    Google Scholar 

  37. Feldman ED, Pingpank JF, Alexander HR, Jr. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol. 2004; 11(3): 290–7.

    Article  PubMed  Google Scholar 

  38. Leyvraz S, Spataro V, Bauer J, et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol. 1997; 15(7): 2589–95.

    PubMed  CAS  Google Scholar 

  39. Peters S, Voelter V, Zografos L, et al. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol. 2006; 17(4): 578–83.

    Article  PubMed  CAS  Google Scholar 

  40. Siegel R, Hauschild A, Kettelhack C, et al. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma. Eur J Surg Oncol. 2007; 33(5): 627–32.

    Article  PubMed  CAS  Google Scholar 

  41. Ueda H, Hamagami H, Tanaka H, et al. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver. Oncol Rep. 2005; 14(6): 1543–6.

    PubMed  Google Scholar 

  42. Cantore M, Fiorentini G, Aitini E, et al. Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumor. 1994; 80(1): 37–9.

    Google Scholar 

  43. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer. 1995; 76(9): 1665–70.

    Article  PubMed  CAS  Google Scholar 

  44. Sato T, Terai M, Huandong Y. Systemic immune response after immunoembolization of liver metastasis with granulocyte-macrophage colony stimulating factor (GM-CSF). Proc Am Assoc Cancer Res. 2002; 43: 914.

    Google Scholar 

  45. Carrasco CH, Wallace S, Charnsangavej C, et al. Treatment of hepatic metastases in ocular melanoma. Embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA. 1986; 255(22): 3152–4

    Article  PubMed  CAS  Google Scholar 

  46. Mavligit GM, Charnsangavej C, Carrasco CH, et al. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA. 1988; 260(7): 974–6.44.

    Article  PubMed  CAS  Google Scholar 

  47. Agarwala SS, Panikkar R, Kirkwood JM. Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res. 2004; 14(3): 217–22.

    Article  PubMed  CAS  Google Scholar 

  48. Feun LG, Reddy KR, Scagnelli T, et al. A phase I study of chemoembolization with cisplatin, thiotepa, and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol. 1999; 22(4): 375–80.

    Article  PubMed  CAS  Google Scholar 

  49. Patel K, Sullivan K, Berd D, et al. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res. 2005; 15(4) 297–304.

    Article  PubMed  Google Scholar 

  50. Alexander HR Jr, Bartlett DL, Libutti SK, et al. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol. 1998;16(4):1479–89.

    PubMed  CAS  Google Scholar 

  51. Libutti SK, Barlett DL, Fraker DL, Alexander HR. Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg. 2000; 191(5): 519–30.

    Article  PubMed  CAS  Google Scholar 

  52. Alexander HR, Libutti SK, Bartlett DL, et al. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res. 2000; 6(8): 3062–70.

    PubMed  CAS  Google Scholar 

  53. Noter SL, Rothbarth J, Pijl ME, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res. 2004; 14(1): 67–72.

    Article  PubMed  CAS  Google Scholar 

  54. Ravikumar TS, Pizzorno G, Bodden W, et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol. 1994; 12(12): 2723–36.

    PubMed  CAS  Google Scholar 

  55. Pingpank JF, Libutti SK, Chang R, et al. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol. 2005; 23(15): 3465–74.

    Article  PubMed  CAS  Google Scholar 

  56. Fety R, Lucas C, Solere P, et al. Hepatic intra-arterial infusion of fotemustine: pharmacokinetics. Cancer Chemother Pharmacol. 1992; 31(2): 118–22.

    Article  PubMed  CAS  Google Scholar 

  57. Keilholz U, Scheibenbogen C, Brado M, et al. Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases. Eur J Cancer. 1994; 30A(1): 103–5.

    Article  PubMed  CAS  Google Scholar 

  58. Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P. Hepatic chemoembolization: safety with portal vein thrombosis. J Vasc Interv Radiol. 1993; 4(3): 347–51.

    Article  PubMed  CAS  Google Scholar 

  59. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2002; 13(9 Pt 2): S211–21.

    Article  PubMed  Google Scholar 

  60. Vogl T, Eichler K, Zangos S, et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol. 2007; 133(3): 177–84.

    Article  PubMed  CAS  Google Scholar 

  61. Grover A, Alexander HR Jr. The past decade of experience with isolated hepatic perfusion. Oncologist. 2004; 9(6): 653–64.

    Article  PubMed  Google Scholar 

  62. Alexander HR Jr, Bartlett DL, Libutti SK. Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver. Cancer J Sci Am. 1998; 4(1): 2–11.

    PubMed  Google Scholar 

  63. Duh EJ, Schachat AP, Albert DM, Patel SM. Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol. 2004; 122(2): 285–7.

    Article  PubMed  Google Scholar 

  64. Mondragon-Sanchez R, Barrera-Franco JL, Cordoba-Gutierrez H, Meneses-Garcia A. Repeat hepatic resection for recurrent metastatic melanoma. Hepatogastroenterology. 1999; 46(25): 459–61.

    PubMed  CAS  Google Scholar 

  65. Gunduz K, Shields JA, Shields CL, et al. Surgical removal of solitary hepatic metastasis from choroidal melanoma. Am J Ophthalmol. 1998; 125(3): 407–9.

    Article  PubMed  CAS  Google Scholar 

  66. Vauthey JN, Winter MW, Blumgart LH. Solitary metastasis from cutaneous melanoma to the liver: resection by extended left hepatectomy (trisegmentectomy) with clearance of tumor from the portal vein. HPB Surg. 1994; 8(1): 53–6.

    Article  PubMed  CAS  Google Scholar 

  67. Papachristou DN, Fortner JJ. Surgical treatment of metastatic melanoma confined to the liver. Int Surg. 1983; 68(2): 145–8.

    PubMed  CAS  Google Scholar 

  68. Stoelben E, Sturm J, Schmoll J, et al. [Resection of solitary liver metastases of malignant melanoma]. Chirurg. 1995; 66(1): 40–3; discussion 43–4.

    PubMed  CAS  Google Scholar 

  69. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000; 89(7): 1561–8.

    Article  PubMed  CAS  Google Scholar 

  70. Fournier GA, Albert DM, Arrigg CA, et al. Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol. 1984; 102(1): 80–2.

    Article  PubMed  CAS  Google Scholar 

  71. Harrison LE, Brennan MF, Newman E, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery. 1997; 121(6): 625–32.

    Article  PubMed  CAS  Google Scholar 

  72. Herman P, Machado MA, Montagnini AL, et al. Selected patients with metastatic melanoma may benefit from liver resection. World J Surg. 2007; 31(1): 171–4.

    Article  PubMed  Google Scholar 

  73. Hsueh EC, Essner R, Foshag LJ, et al. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer. 2004; 100(1): 122–9.

    Article  PubMed  Google Scholar 

  74. Crook TB, Jones OM, John TG, Rees M. Hepatic resection for malignant melanoma. Eur J Surg Oncol. 2006; 32(3): 315–7.

    Article  PubMed  CAS  Google Scholar 

  75. Rivoire M, Kodjikian L, Baldo S, et al. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol. 2005; 12(6): 422–8.

    Article  PubMed  Google Scholar 

  76. Gutman H, Hess KR, Kokotsakis JA, et al. Surgery for abdominal metastases of cutaneous melanoma. World J Surg. 2001; 25(6): 750–8.

    Article  PubMed  CAS  Google Scholar 

  77. Essner R, Lee JH, Wanek LA, et al. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg. 2004; 139(9): 961–6; discussion 966–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fellow, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Debashish Bose

  2. Assistant Professor of Surgery Department of Surgery, Division of Surgical Oncology, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Timothy M. Pawlik

Authors
  1. Debashish Bose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy M. Pawlik
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, Dept. Surgical Oncology, University of Texas, Holcombe Blvd. 1515, Houston, 77030, Texas, USA

    Jean-Nicolas Vauthey

  2. São Paulo, Faculdade de Medicina da, Universidade de São Paulo,, Instituto do Cancer do Estado de, Ave Dr Arnaldo 251, São Paulo, 01246-000, São Paulo, Brazil

    Paulo M. Hoff

  3. University of Liverpool, St Helens Teach, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  4. Center for Digestive Diseases, University Hospital Aintree, Lower Lane, Liverpool, L9 7AL, United Kingdom

    Graeme J. Poston

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London

About this chapter

Cite this chapter

Bose, D., Pawlik, T.M. (2009). Liver-Directed Therapy for Metastatic Melanoma to the Liver. In: Vauthey, JN., Hoff, P., Audisio, R., Poston, G. (eds) Liver Metastases. Springer, London. https://doi.org/10.1007/978-1-84628-947-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-947-7_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-946-0

  • Online ISBN: 978-1-84628-947-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation